Navigation Links
ERT Integrates Circassia’s FeNO Device to Assess Patient Airway Inflammation
Date:5/17/2016

ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, today announced it has successfully integrated the market-leading Fractional exhaled Nitric Oxide (FeNO) measurement device by Aerocrine—a Circassia subsidiary— into ERT’s diagnostic platform for spirometry, ECG and home monitoring for centralized clinical trials.

NIOX VERO® is Circassia’s FeNO solution, and it integrates with ERT’s market-leading platform, MasterScope™. The integrated solution is available immediately for clinical trials.

“We are pleased to offer NIOX VERO integration for our biopharmaceutical customers,” said Achim Schülke, Executive Vice President, Respiratory Solutions at ERT. “By automating workflows with MasterScope, clinical trial sponsors will benefit from enhanced FeNO quality monitoring, protocol compliance, and patient performance as well as reduced investigative site burden.”

Patients with allergic airway inflammation have higher than normal levels of nitric oxide in their exhaled breath. By measuring FeNO in accordance with American Thoracic Society and European Respiratory Society guidelines, clinicians can evaluate and compare allergic airway inflammation in patients with underlying asthma.

“We are pleased to continue our ongoing partnership with ERT and to collaborate on solutions that improve efficiencies and outcomes for asthma patients, clinical study investigators and sponsors,” said Linda Szyper, Circassia’s Chief Commerical Officer.

Supported on MasterScope, NIOX VERO and previous generation NIOX MINO® are cleared by the FDA and approved for use in global trials by many worldwide regulators.

For more information on ERT’s suite of Respiratory Solutions, visit http://www.ert.com/respiratory.

About ERT
ERT is a leading provider of high-quality patient data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the efficiency of the clinical development process. ERT delivers widely deployed solutions in centralized Cardiac Safety, Respiratory, and electronic Clinical Outcome Assessments (eCOA) – which includes patient-, clinician-, observer- and performance-reported outcomes – and cloud-based analytics and performance metrics. By efficiently integrating these solutions through a system built upon a scientific and regulatory foundation, ERT collects, analyzes and delivers safety and efficacy data critical to the approval, labeling and reimbursement of pharmaceutical products. For more information see http://www.ert.com. Join ERT on LinkedIn, Twitter, YouTube and Facebook.

About Circassia
Circassia is a world-class specialty biopharmaceutical business focused on allergy and respiratory disease. Circassia sells its novel, market-leading products for asthma management directly to allergy / asthma specialists in the United States and Germany. Its products are also promoted in a number of other countries by the Company’s international network of partners. For more information on Circassia please visit http://www.circassia.com.

Read the full story at http://www.prweb.com/releases/2016/05/prweb13422505.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related medicine news :

1. Virtual Observer Workforce Optimization Solution Integrates with Zendesk’s Ticketing, Voice, Social Media and Chat Features
2. XtreMed Successfully Integrates Radiology Technology with T-System's EDIS, Streamlining Care for Neighbors Emergency Center
3. SIGNiX Integrates Support for Wacom Signature Pads into its Independent E-Signature™ Solution
4. iPatientCare Successfully Integrates with Wellcentive to Move One Step Ahead Towards Managing the Care Process for Populations
5. CSI's Virtual Observer Integrates with Clarity Connect to Provide Complete Workforce Optimization Capabilities for Skype for Business Contact Center Customers
6. Barnard Medical Center Integrates Nutrition and Medicine Into Complete Primary Care
7. Cloud Access Security Broker Sookasa Integrates with Slack to Deliver Unprecedented Visibility and Control
8. Allegheny Health Network Launches Healthcare@HomeNew Program Uniquely Integrates a Spectrum of Home-Based Health Services
9. Visage 7 Integrates Multimedia Reporting at RSNA 2015
10. Senior Catalent Executives Invited to Give Expert Opinion on Drug Development and Partnering Strategies at Upcoming Pharma Integrates Conference
11. FOTO’s Outcomes Reporting System Integrates With Clinicient’s Insight Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... Announced that ... clinical and commercial support services market) has entered into an agreement on September ... , The PGSD is the first private Dental School to launch an ...
(Date:9/20/2017)... ... September 20, 2017 , ... Each year Athletic ... National Athletic Trainers’ Association Annual Clinical Symposium and Expo. New research is revealed, ... when Athletic Trainers are acknowledged by their peers with accolades and highly prestigious ...
(Date:9/20/2017)... ... September 20, 2017 , ... Five consumer packaged goods (CPG) products were selected ... different categories. Nopavera Plus was named to the short list in the ... West 2017 during presentations at SupplySide Central on Sept. 27 and 28 at Mandalay ...
(Date:9/20/2017)... ... ... Health & Safety Institute (HSI) is offering discounted pricing on its Summit ... now until November 30, 2017 to assist with the clean-up efforts from hurricanes Harvey ... and government agencies – whether or not they will be directly involved in the ...
(Date:9/20/2017)... ... September 20, 2017 , ... “RECYCLED Ezekiel's Plan for Freedom ... Freedom from ADDICTION” is the creation of published author, Bill Miller. Bill ... homeless services, including more than a decade of addiction to prescription drugs. ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017 NeuroRx, a clinical ... Suicidal Ideation and Behavior (ASIB), has been granted Fast Track ... sequential therapy of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine ... a pivotal trial of this sequential therapy targeting patients who ... 1 ...
(Date:9/5/2017)... Pa. , Sept. 5, 2017  Xyntek Inc. has announced another milestone ... a new Midwest office to meet the growing demands of customer engagements regionally.  ... Xyntek's new Midwest office is located at 318 ... ... of customer engagements regionally. ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... company focused on the development of oral drug delivery ... meeting with the U.S. Food and Drug Administration (FDA) ... At the meeting, the ... submission of ORMD-0801, would be a Biologics License Application ...
Breaking Medicine Technology: